Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07002294

The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)

This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers.

The main question that it will answer is whether transferring participants to a hospital with a specialized cardiac arrest service improves recovery of function after 90 days.

Participants will receive all usual medical care, but some participants will be offered transfer to a regional cardiac arrest center and others will be offered care at the closest appropriate hospital. Investigators will interview participants after 90 days to assess their recovery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pittsburgh Department of Emergency Medicine

Pittsburgh, Pennsylvania, 15213, United States

Location contact

Clifton Callaway, MD, PhD

SUB_INVESTIGATOR

Francis Guyette, MD, MPH

SUB_INVESTIGATOR

Jonathan Elmer, MD, MS

PRINCIPAL_INVESTIGATOR

Sara DiFiore-Sprouse

CONTACT

[email protected]

4128642284

About this study

Cardiac arrest is a sudden stopping of the heart, which can sometimes be reversed by rapid cardiopulmonary resuscitation (CPR) and emergency medical care. Each year, over 150,000 Americans are admitted to the hospital after receiving CPR. However, many of these patients die in the hospital. There is wide variation in patient outcomes between hospitals. A key knowledge gap about systems of care is whether specific hospital or subsequent interventions or processes of care are associated with better patient outcomes. Specifically, it is unknown if patient outcomes are improved by specialized centers or by improved implementation of recommended interventions at all hospitals.

Observational data in our region and internationally suggest that out-of-hospital cardiac arrest outcomes are better when patients who survive CPR are hospitalized in specialty care or high-volume centers. It is unclear from these studies what are the minimal capabilities that distinguish specialty care from usual care and which aspects of specialty care are influencing outcomes.

This trial will take advantage of a regional system of care that includes 18 hospitals in southwestern Pennsylvania that treat over 1,000 patients resuscitated from out-of-hospital cardiac arrest annually. This region includes one high-volume specialty center with specific attention to recommended interventions for this patient population, as well as several secondary and tertiary care facilities with variable resources and approaches to patient care. This randomized trial will compare outcomes for patients assigned to care at the specialty center versus other centers and will leverage the heterogeneity of treatment between centers to understand the influence of specific treatments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Out-of-hospital cardiac arrest
  • Resuscitated from cardiac arrest with palpable pulse in the emergency department
  • Treated at one of participating hospital emergency departments
  • Age ≥18 years

Exclusion criteria

  • Known prior advanced directives or decision to limit critical care
  • Known pre-arrest dependent functional status (e.g., living in a skilled nursing facility, hospice or bedbound)
  • Arrest in the emergency department >4 hours after arrival
  • Traumatic etiology of arrest
  • Known to have opted-out from the SPARC trial

Treatment and study plan

Transfer to specialty care

Other

Interfacility transport and treatment at the specialty care hospital

Usual Care

Other

Hospitalization and treatment at the closest appropriate facility

Primary outcomes

  1. Modified Rankin Scale

    Time frame: 90 Days post arrest

    The Modified Rankin Scale (mRS) is a measure of functional recovery, measured 90 days after cardiac arrest. A Modified Rankin Score (mRS) of 0 corresponds to full functional recovery and a Modified Rankin Score (mRS) of 6 corresponds to death, with progressively worse functional outcomes at higher scores. Intermediate values reflect progressive functional dependence, with higher scores reflecting greater dependence on others.

Secondary outcomes

  1. Survival to ICU Admission

    Time frame: 24 hours post arrest

  2. 72 hour survival

    Time frame: 72 hours post arrest

  3. mRS at hospital discharge

    Time frame: Up to 6 months post arrest

Study contacts

Contact information is provided by the study sponsor or research team.

Sara DiFiore-Sprouse

CONTACT

[email protected]

4128642284

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: SPARC

Important dates

Study start
2026
Primary completion
2031
Study completion
2032
First posted
Jun 3, 2025
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.